Login to Your Account

Proteostasis raises $50M in IPO, but with big discount

By Michael Fitzhugh
Staff Writer

Thursday, February 11, 2016

Despite pricing well below range, an upsized IPO by cystic fibrosis drug developer Proteostasis Therapeutics Inc.  fell 17 percent during its first day of trading Thursday.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription